Benzoic Acid

Benzoic Acid

SCHEMBL6399739

O=C(O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.O=C(O)c1ccccc1.O=C(O)c1ccccc1.O=C(O)c1ccccc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.46
LGALS9 O00182 2/20 0.46
LGALS1 P09382 2/20 0.46
LGALS3 P17931 2/20 0.46
LGALS7; LGALS7B P47929 2/20 0.46
HK1 P19367 2/20 0.45
HK2 P52789 2/20 0.45
IDUA P35475 1/20 0.45
DAO P14920 1/20 0.44
TSHR P16473 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL6402163 0.85 PYGL (0.43) PYGLLGALS9LGALS1LGALS3LGALS7; LGALS7B
Dextrose SCHEMBL19252827 0.84 HK1 (0.53) PYGLLGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL27745076 0.84 EPHX1 (0.50) LGALS9LGALS1LGALS3LGALS7; LGALS7BHK1
SCHEMBL28137386 0.83 IDUA (0.60) LGALS9LGALS1LGALS3IDUA
SCHEMBL9000840 0.83 IDUA (0.60) LGALS9LGALS1LGALS3IDUA
SCHEMBL27758954 0.83 IDUA (0.60) LGALS9LGALS1LGALS3IDUA
SCHEMBL27738037 0.83 IDUA (0.60) LGALS9LGALS1LGALS3IDUA
SCHEMBL7152160 0.83 IDUA (0.60) LGALS9LGALS1LGALS3IDUA
SCHEMBL12940641 0.81 IDUA (0.63) LGALS9LGALS1LGALS3IDUA
SCHEMBL9524161 0.81 IDUA (0.63) LGALS9LGALS1LGALS3IDUA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009777-A1 Non-natural carbon-linked nucleotides and dinucleotides CELLTECH R & D LIMITED (GB) 2005-01-13 US disclosed
EP-1409503-A1 NON-NATURAL CARBON-LINKED NUCLEOTIDES AND DINUCLEOTIDES Celltech R & D Limited (GB) 2004-04-21 EP disclosed
WO-2003011885-A1 NON-NATURAL CARBON-LINKED NUCLEOTIDES AND DINUCLEOTIDES CELLTECH R & D LIMITED (GB) 2003-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009777-A1 Non-natural carbon-linked nucleotides and dinucleotides P2RY1, P2RY11, P2RY13 PYGL 395/4885LGALS9 847/4885LGALS1 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.